Treatment of actinic keratoses with alpha.sub.2 interferon

Details Treatment of actinic keratoses with alpha.sub.2 interferon Treatment of actinic keratoses with alpha.sub.2 interferon

1989-08-22

1991-03-26

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 854, A61K 3766

Patent

active

050027646

ABSTRACT:
A method of treating actinic keratoses with alpha.sub.2 interferon is disclosed.

REFERENCES:
patent: 4605555 (1986-08-01), Sato et al.
Yancey et al., Am. Acad. Dermatol., 3, No. 6 (1980), 585-595.
Rubenstein, Biochem. Biophys. Acta, 695 (1982), 5-16.
Nagata et al., Nature, 284, (1980), 316-320.
Edwards et al., Arch. Dermatol., 122 (Jul., 1986) pp. 779-782.
Langer et al. J. of Invest. Dermatology 83, (1984), pp. 1285-1365.
Yusk, Current Therapy, ed. Comm, pp. 643-645, 1979.
Ikic et al., The Lancet, pp. 1025-1027, May 9, 1981.

Affiliated with

Also associated with

Rating

Treatment of actinic keratoses with alpha.sub.2 interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of actinic keratoses with alpha.sub.2 interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of actinic keratoses with alpha.sub.2 interferon will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-616126